Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Investing

Pfizer : PFE

All Pfizer Articles

1508 Articles

Paul Ausick | Apr 11, 2017 at 4:01 PM EDT

Apple, DuPont Sink DJIA Tuesday

Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.

Chris Lange | Mar 27, 2017 at 8:35 AM EDT

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 27, 2017 at 6:50 AM EDT

The 6 Most Shorted NYSE Stocks

With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by…

Chris Lange | Mar 25, 2017 at 9:15 AM EDT

How Health Care Stocks Responded to the Shelved Health Care Bill

24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen…

Paul Ausick | Mar 24, 2017 at 4:01 PM EDT

DuPont, Boeing Sink DJIA Friday

Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.

Paul Ausick | Mar 16, 2017 at 4:05 PM EDT

DuPont, Chevron Take DJIA Down Thursday

DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.

Chris Lange | Mar 10, 2017 at 8:55 AM EST

Short Sellers Back Off Major Pharma

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Mar 10, 2017 at 6:10 AM EST

The 6 Most Shorted NYSE Stocks

The bull market is now eight years old, and markets still keep on hitting new highs. How have the short…

Paul Ausick | Mar 7, 2017 at 4:01 PM EST

Chevron, Verizon Sink DJIA on Tuesday

Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.

Chris Lange | Mar 6, 2017 at 9:50 AM EST

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type…

Chris Lange | Feb 28, 2017 at 8:55 AM EST

Why Short Sellers Are Making a Massive Bet in Major Pharma

Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.

Trey Thoelcke | Feb 28, 2017 at 6:15 AM EST

The 6 Most Shorted NYSE Stocks

The nearly eight-year old bull market endures, with markets recently hitting all-time highs. And how are short sellers reacting?

Paul Ausick | Feb 23, 2017 at 4:01 PM EST

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Johnson & Johnson, Pfizer, UnitedHealth, and Verizon lifted the DJIA on Thursday.

Paul Ausick | Feb 16, 2017 at 12:45 PM EST

Apple Named World’s Most Innovative Company

2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were…

Paul Ausick | Feb 15, 2017 at 4:01 PM EST

Pfizer, Cisco Push DJIA Higher Wednesday

Pfizer, Cisco, JPMorgan, and Procter & Gamble lead the DJIA to another record high on Wednesday.

1 … 43 44 45 46 47 … 101

Pfizer : PFE

All Pfizer Articles

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

The 6 Most Shorted NYSE Stocks

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Apple Named World’s Most Innovative Company

Pfizer, Cisco Push DJIA Higher Wednesday

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Cramer Just Turned Bearish for the First Time Since 2000: “We’re Out of Money”

Jim Cramer: SK Hynix Is the Last Big IPO of 2026 Unless a Hyperscaler Shocks Us

Why I Can’t Stop Buying This “Boring” Chipmaker With Game Changing Upside

Where to Park a House Down Payment You Need in Two Years

He Claimed Social Security at 62 Against His Advisor's Advice. At 78, His $900,000 Portfolio Says It Was the Right Call.

Webull Stock Is One to Watch as Trading Activity Picks Up

Cramer Just Turned Bearish for the First Time Since 2000: “We’re Out of Money”

Pfizer : PFE

All Pfizer Articles

Apple, DuPont Sink DJIA Tuesday

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

The 6 Most Shorted NYSE Stocks

How Health Care Stocks Responded to the Shelved Health Care Bill

DuPont, Boeing Sink DJIA Friday

DuPont, Chevron Take DJIA Down Thursday

Short Sellers Back Off Major Pharma

The 6 Most Shorted NYSE Stocks

Chevron, Verizon Sink DJIA on Tuesday

Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here

Why Short Sellers Are Making a Massive Bet in Major Pharma

The 6 Most Shorted NYSE Stocks

Johnson & Johnson, Pfizer Lead DJIA Higher on Thursday

Apple Named World’s Most Innovative Company

Pfizer, Cisco Push DJIA Higher Wednesday

Live Nasdaq Composite: Tech Bulls Circle amid SK Hynix’s US Market Debut

Cramer Just Turned Bearish for the First Time Since 2000: “We’re Out of Money”

Jim Cramer: SK Hynix Is the Last Big IPO of 2026 Unless a Hyperscaler Shocks Us

Why I Can’t Stop Buying This “Boring” Chipmaker With Game Changing Upside

Featured Reads

Where to Park a House Down Payment You Need in Two Years

He Claimed Social Security at 62 Against His Advisor's Advice. At 78, His $900,000 Portfolio Says It Was the Right Call.